Elanco Animal Health (ELAN) Receivables - Other (2017 - 2026)
Elanco Animal Health (ELAN) posted Receivables - Other of $70.0 million for Q1 2026, up 4.48% sequentially from $67.0 million in Q4 2025, and down 22.22% YoY from $90.0 million in Q1 2025.
Elanco Animal Health (ELAN) Receivables - Other (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Receivables - Other for 10 years, with the latest figure at $70.0 million in Q1 2026.
- Quarterly Receivables - Other fell 22.22% year-over-year to $70.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.0 million (down 22.22% YoY) and the FY2025 annual result came in at $67.0 million, down 17.28% from the prior year.
- Receivables - Other grew to $70.0 million in Q1 2026 per ELAN's latest filing, from $67.0 million in the prior quarter.
- Over five years, Receivables - Other peaked at $225.0 million in Q2 2023 and troughed at $64.0 million in Q3 2024.
- A 5-year average of $142.8 million and a median of $114.0 million in 2025 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2024: Receivables - Other surged 110.58% in 2022, then tumbled 71.43% in 2024.
- Over 5 years, Receivables - Other stood at $205.0 million in 2022, then fell by 18.05% to $168.0 million in 2023, then tumbled by 51.79% to $81.0 million in 2024, then declined by 17.28% to $67.0 million in 2025, then advanced by 4.48% to $70.0 million in 2026.
- According to Business Quant data, Receivables - Other over the past three periods registered $70.0 million, $67.0 million, and $81.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75.00 Mn |
| Jun 30, 2026 | 75.00 Mn |
| Mar 31, 2026 | 70.00 Mn |
| Mar 31, 2026 | 70.00 Mn |
| Dec 31, 2025 | 67.00 Mn |
| Dec 31, 2025 | 67.00 Mn |
| Sep 30, 2025 | 81.00 Mn |
| Sep 30, 2025 | 81.00 Mn |
| Jun 30, 2025 | 114.00 Mn |
| Jun 30, 2025 | 114.00 Mn |
| Mar 31, 2025 | 90.00 Mn |
| Mar 31, 2025 | 90.00 Mn |
| Dec 31, 2024 | 81.00 Mn |
| Dec 31, 2024 | 81.00 Mn |
| Sep 30, 2024 | 64.00 Mn |
| Sep 30, 2024 | 64.00 Mn |
| Jun 30, 2024 | 81.00 Mn |
| Jun 30, 2024 | 81.00 Mn |
| Mar 31, 2024 | 90.00 Mn |
| Mar 31, 2024 | 90.00 Mn |